As the novel coronavirus (COVID-19) sweeps the world in devastating fashion, scientists are scrambling to develop effective vaccines and treatments. But how should those medicines be priced globally? Following Donald Trump’s “America First” policy with respect to vaccine and drug pricing would be tragic, argue Quenten Palfrey and John Stubbs. Instead, Palfrey and Stubbs propose a pharmaceutical pricing policy modeled on progressive taxation to distribute costs equitably worldwide. This discussion was moderated by Ashveena Gajeelee.